An Open-Label, Phase 1b Study of ACP-196 Alone or in Combination with Rituximab in Subjects with folicular Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date8/4/15 → 8/3/16

Funding

  • Acerta Pharma ( Award # ): $8,615.00